Weight loss,
without judgement with your muscle intact with a plan for after priced honestly that works

Kaivo combines clinical care with daily support. Your plan includes a 35-marker blood panel, video consults with an AIIMS-trained specialist, a dedicated coach, daily WhatsApp support, and a GLP-1 prescription if it's clinically right for you. You make meaningful, sustainable progress with small changes in food, movement, and sleep — backed by AIIMS-grade medical care.

Every plan includes:

• Doctor consultations — monthly on Essential, twice-monthly on Premium, all with an AIIMS-trained specialist
• Clinical nutritionist — monthly sessions on Essential; dedicated nutritionist and health coach on Premium
• Diagnostics — 12-marker baseline panel with the Discovery consult; quarterly 35-marker panel on Premium
• Chat support — WhatsApp support from the clinic team on both plans
• Medicine — bought separately from a licensed pharmacy. No markup, full transparency

Most patients notice reduced hunger within 1–2 weeks. Visible weight loss usually starts around weeks 4–6. By month 3, most have lost 4–7%; by month 6, 12–18%. Our patients average 15.4% body-weight loss at 12 months. Consistency matters — your team is with you every step.

Your plan is built by an AIIMS-trained medical specialist after reviewing your 35-marker panel, medical history, and goals. A dedicated coach and clinical dietitian support delivery. The plan is reviewed every 90 days as your labs and progress evolve — not set once and forgotten.

Three things. AIIMS doctors only — every specialist on Kaivo trained at AIIMS, no general practitioners. Built for Indian bodies — vegetarian protein gaps, PCOS, festival eating, and Indian visceral-fat patterns are baked into every protocol. Maintenance from day one — we design the taper and the post-medication plan up front. 82% of our patients keep most of their loss at 24 months.

Yes — fast for 12 hours before your blood draw. No food or beverages such as tea, coffee, or juice. Water is fine. If you can't fast the full 12 hours, reschedule rather than test — accurate baseline labs are the foundation of your entire plan.

Yes. Ozempic (semaglutide) launched in India in December 2025 (CDSCO-approved September 2025) and is available with a doctor's prescription from licensed pharmacies. Wegovy (the higher-dose weight-loss version of semaglutide) and Mounjaro (tirzepatide) are also available in India under prescription. Kaivo connects you with AIIMS-trained doctors who can prescribe these medications if they are clinically right for you.

At Indian retail pharmacies, after Novo Nordisk's April 2026 price cut, Ozempic starts at about ₹5,660/month for the 0.25 mg dose and rises to roughly ₹9,100 at the 1 mg dose, with one pen lasting ~4 weeks. Mounjaro pens cost roughly ₹13,125–₹16,406 (2.5–5 mg). Generic semaglutide — launched after the March 2026 patent expiry — is the cheapest, from about ₹1,290/month, but verify the source. Kaivo charges a separate flat program fee starting at ₹2,499/month and helps you buy medication directly from a licensed pharmacy at no markup. See the full 2026 cost breakdown for every GLP-1 medication.

No. Semaglutide and tirzepatide are Schedule H prescription-only drugs in India. Selling them without a valid prescription from a registered medical practitioner is illegal. Counterfeit GLP-1 medication is a known global problem — always get a prescription from a qualified doctor and buy only from a licensed pharmacy. Any MBBS-registered doctor can prescribe these medicines; our guide to which doctor to consult for Mounjaro in India covers consult costs, tests, and legal online prescriptions.

A one-off prescription gets you the medication, but not the system around it. Kaivo provides ongoing supervision by AIIMS-trained specialists, a dedicated nutritionist for Indian dietary patterns (vegetarian protein gaps, PCOS, festival eating), a 35-marker panel reviewed every 90 days, WhatsApp access between consults, and a planned taper and maintenance phase from day one. 82% of Kaivo patients keep most of their weight loss at 24 months.

Consultations are entirely online via secure video, scheduled through Calendly. You complete a short health quiz, book a Discovery consult, get your baseline blood draw at a partner lab near you, then begin your program. No clinic visit needed; medication ships to your home from a licensed pharmacy.

Yes — Kaivo plans are month-to-month with no lock-in. Cancel anytime through your account or by emailing care@getkaivo.in. If you cancel partway through a billing cycle, your current month stays active until period end. No cancellation fee. Refunds for unused upfront diagnostics follow our refund policy.

The best program is the one that wraps a real clinical system around the medication — not just a prescription. Judge any GLP-1 provider on five things: specialist doctors (ideally AIIMS-trained), a baseline blood panel with follow-up labs, a diet plan built for Indian eating (vegetarian protein, PCOS, festivals), support between consults, and a maintenance plan for after you stop the drug. Kaivo was built around exactly these five, starting at ₹2,499/month.

In the SURMOUNT-1 trial, adults on the highest tirzepatide dose lost an average of 20.9% of body weight over 72 weeks with diet and exercise. On a supervised program most Indian patients lose 4–7% by month 3 and 12–18% by month 6–9, depending on starting weight, dose, and adherence. The numbers need the right dose ladder, nutrition, and follow-up — they are not automatic. If your loss has flattened, read our guide on what to do when Mounjaro stalls.

For weight loss, tirzepatide (Mounjaro) beat semaglutide (Ozempic/Wegovy) head-to-head in the SURMOUNT-5 trial, because it targets two gut hormones (GLP-1 and GIP) instead of one. Semaglutide has the longer cardiovascular-outcome record. The right pick depends on your starting weight, diabetes status, side-effect tolerance, and budget — a doctor should decide, not a comparison table.

After semaglutide's Indian patent expired in March 2026, generic semaglutide became the cheapest option — from about ₹1,290/month, roughly 80–90% below the innovator brands. Among innovator brands, after the April 2026 Novo Nordisk price cut, Ozempic and Wegovy start at about ₹5,660/month (0.25 mg dose). Cheapest isn't safest: only buy from a licensed pharmacy on a valid prescription — counterfeit GLP-1 pens are a documented problem in India.

Some regain is common if you stop abruptly with no plan — trials show people regain a large share of lost weight within a year of stopping. That's why the maintenance phase matters: a gradual taper, protein and resistance training to protect muscle, and continued habit support. Kaivo designs the post-medication plan from day one instead of dropping you when the prescription ends.

Start by confirming you're a clinical candidate — not by buying a pen online. The safe path: a short health check, a baseline blood panel, a consult with a qualified doctor who decides if a GLP-1 is right for you, then a prescription filled at a licensed pharmacy and a slowly titrated dose under supervision. With Kaivo that's one flow: a 2-minute quiz → Discovery consult with an AIIMS-trained doctor → baseline labs → your program.

Kaivo is an online program available across India. Consults happen by secure video, your baseline blood draw is done at a partner lab near you, and medication is shipped to your home from a licensed pharmacy. You don't need to live in a metro or visit a clinic in person.